Old Web
English
Sign In
Acemap
>
Paper
>
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19.
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19.
2021
Fang Sun
Chenglin Mu
Hang Fai Kwok
Jiyuan Xu
Yingliang Wu
Wanhong Liu
Jean Marc Sabatier
Cédric Annweiler
Xugang Li
Zhijian Cao
Yingqiu Xie
Keywords:
akt inhibitor
Chlorocebus aethiops
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Virology
Vero cell
2019 20 coronavirus outbreak
Proto-Oncogene Proteins c-akt
Biology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
21
References
1
Citations
NaN
KQI
[]